Cargando…

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Antibody responses develop following SARS-CoV-2 infection, but little is known about their epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We isolated B cells specific for the SARS-CoV-2 envelope glycoprotein spike (S) from a COVID-19-infected subject 21 da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seydoux, Emilie, Homad, Leah J., MacCamy, Anna J., Parks, K. Rachael, Hurlburt, Nicholas K., Jennewein, Madeleine F., Akins, Nicholas R., Stuart, Andrew B., Wan, Yu-Hsin, Feng, Junli, Whaley, Rachael E., Singh, Suruchi, Boeckh, Michael, Cohen, Kristen W., McElrath, M. Juliana, Englund, Janet A., Chu, Helen Y., Pancera, Marie, McGuire, Andrew T., Stamatatos, Leonidas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276322/ https://www.ncbi.nlm.nih.gov/pubmed/32561270 http://dx.doi.org/10.1016/j.immuni.2020.06.001

Ejemplares similares

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
por: Seydoux, Emilie, et al.
Publicado: (2020)

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
por: Jennewein, Madeleine F., et al.
Publicado: (2021)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
por: Seydoux, Emilie, et al.
Publicado: (2021)

A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
por: Gray, Matthew D., et al.
Publicado: (2022)

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
por: Parks, K. Rachael, et al.
Publicado: (2019)

Adjuvants influence the maturation of VRC01-like antibodies during immunization
por: Knudsen, Maria L., et al.
Publicado: (2022)

Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
por: Dosenovic, Pia, et al.
Publicado: (2019)

Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus
por: Singh, Swati, et al.
Publicado: (2020)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies
por: Whaley, Rachael E., et al.
Publicado: (2021)

Linear analysis and differential equations
por: MacCamy, Richard C, et al.
Publicado: (1969)

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
por: Borst, Andrew J, et al.
Publicado: (2018)

923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Xie, Hu, et al.
Publicado: (2021)

Emergent Electroweak Gravity
por: McElrath, Bob
Publicado: (2008)

Laboratory tests for the cosmic neutrino background using beta-decaying nuclei
por: McElrath, Bob
Publicado: (2009)

On The Origin of Neutrino Mass and Mixing in the Standard Model
por: McElrath, Bob
Publicado: (2009)

Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge
por: Malhi, Harman, et al.
Publicado: (2022)

Protective antibodies against human parainfluenza virus type 3 infection
por: Boonyaratanakornkit, Jim, et al.
Publicado: (2021)

Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes
por: Bancroft, Tara, et al.
Publicado: (2019)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

$h \to \mu^{+}\mu^{-}$ via Gluon Fusion at the LHC
por: Han, T, et al.
Publicado: (2002)

HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells
por: Hartweger, Harald, et al.
Publicado: (2019)

There is no explosion risk associated with superfluid Helium in the LHC cooling system
por: Fairbairn, Malcolm, et al.
Publicado: (2008)

mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RA(int) T(EMRA)-like CD8(+) T cells in COVID-19 recovered individuals
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2023)

Management of penetrating abdominal trauma in St Mary's Hospital Major Trauma Centre
por: Fisher, Rachael C, et al.
Publicado: (2015)

Designed proteins assemble antibodies into modular nanocages
por: Divine, Robby, et al.
Publicado: (2020)

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
por: McGuire, Andrew T., et al.
Publicado: (2013)

CXCR3 enables recruitment and site-specific bystander activation of memory CD8(+) T cells
por: Maurice, Nicholas J., et al.
Publicado: (2019)

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Signatures of Extra Dimensions from Upsilon Decays with a Light Gaugephobic Higgs Boson
por: Galloway, Jamison, et al.
Publicado: (2008)

Winning grants step by step: the complete workbook for planning, developing, and writing successful proposals
por: O'Neal-McElrath, Tori, et al.
Publicado: (2013)

Use of B-Cell–Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Galati, Alexandra, et al.
Publicado: (2022)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?
por: Self, S, et al.
Publicado: (2009)

Little Higgs models
por: Grégoire, Thomas, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_li1egikanoihba4akihij7akev